LAPTM5 and renal cell carcinoma: In agreement with the findings in RCC cells, overexpression of LAPTM5 promoted the sphere formation ability of the murine 4T1luci and human MDA-MB-231 breast cancer cell lines in vitro while silencing of Laptm5 suppressed sphere formation (Fig. 8e and Supplementary Fig. 10a–d).